Last updated: 2026-09-09 11:52:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Kezar Life Sciences, Inc. (KZR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Kezar Life Sciences, Inc. (KZR) is trading at $-- in pre-market trading as of --, -- from the previous close of $--
Pre-market trading shows how investors are pricing KZR before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, Kezar Life Sciences, Inc. (KZR) moved from $7.29 to $7.29, representing no net price change.
The stock traded between $7.23 and $7.47 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 170.64 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 9 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Kezar Life Sciences, Inc. (KZR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.